PICS~AICS Special Preview Issue

20 Pages·2015·2.54 MB·English

by  Congenital Cardiology Today

C O N G E N I T A L

C A R D I O L O G Y T O D A Y
Timely News and Information for BC/BE Congenital/Structural Cardiologists and Surgeons
Volume 13 / Issue 7A
Pediatric & Adult Interventional
July 15, 2015
SPECIAL PICS-AICS 2015 PREVIEW Cardiac Symposium (PICS~AICS
North American Edition
2015), with Live Case Demonstrations,
IN THIS ISSUE
to be Held September 18th-21st, 2015,
Pediatric & Adult Interventional
Cardiac Symposium (PICS~AICS
at The Aria Hotel, Las Vegas, NV USA
2015), with Live Case
Demonstrations, to be Held
September 18th-21st, 2015, at By Ziyad M. Hijazi, MD; Damien Kenny, MD with the first report of the use of prostaglandin
The Aria Hotel, Las Vegas, NV USA on behalf of Course Directors and Co-Directors to maintain ductal patency, as well as the true
beginning of device closure with the first report
By Ziyad M. Hijazi, MD; Damien
of ASD closure from Terry King and Noel Mills.
Kenny, MD on behalf of Course
Dear Colleagues, We are honored to have Dr. King talk at the
Directors and Co-Directors
meeting, and give us his perspective on the
~ Page 1
The Pediatric and Adult Interventional Cardiac evolution of ASD closure and part of our pre-
Accreditation ~ Page 6 Symposium – PICS-AICS 2015, is being held rogative is to challenge the new generation to
at the Aria Hotel, Las Vegas from September build on Dr. Kings’s platform to push the
September 17th - Collaboration to 18th-21st, 2015. The focus of this year’s meet- boundaries of interventional therapies for con-
Counter Complexity: The Future of ing is on how we can overcome greater com- genital and structural patients.
Congenital and Structural plexity through collaboration. Hence, we have
Interventions Special One Day
focused sessions outlining opportunities for The live cases remain the focal point of the
Industry-Sponsored Symposium
greater integration with adult structural heart meeting. Live cases will be beamed from nine
at PICS~AICS ~ Page 4
disease specialists and congenital surgeons. national and international venues with experi-
September 18th - PICS Friday As well as integrating the new, we have en- enced operators that will demonstrate the
Session ~ Page 6 deavored to ensure the meeting continues to latest in medical device technology using ap-
support open dialogue, as well as visual learn- proved and investigational devices/valves/
September 19th - PICS ing, along with updates from all the relevant stents, etc. The live cases this year will be
Saturday Session ~ Page 7-8 trials and societies, with real opportunities for transmitted live via satellite from: Riyadh,
networking and sharing global clinical and re- Córdoba, São Paolo, Mumbai, Las Vegas,
September 20th - PICS Sunday
search experience. We will continue to provide Seattle, Columbus, Houston and San Diego.
Session ~ Pages 10-11
a professional but relaxed atmosphere to sup-
port this fantastic learning opportunity with so- This year’s meeting will be proceeded by an
Summary Lives Cases and
Operators ~ Pages 10 cial gatherings to ensure friends can meet and imaging symposium on Thursday evening with
enjoy catching up. discussions concentrated on advanced imag-
September 21st - PICS Monday ing platforms for cardiac catheterization. Imag-
Session ~ Page 12 We really wanted to focus in this year’s meet- ing platforms and radiation reduction constitute
ing on ways we can work together to rise to the one of the great new horizons of catheteriza-
PICS Achievement Award 2015 challenges of the next 40 years. This year sees tion, and we urge you to attend as we will have
~ Page 14
the celebration of great innovations in CHD state-of-the art talks from all the major imaging
Sign-up Now For The 3rd
Annual PICS~AICS 5K RUN
~ Page 15
RECRUITMENT ADVERTISING IN
PICS~AICS Registration
Information ~ Page 16
CONGENITAL CARDIOLOGY TODAY
Guest Faculty ~ Page 16
PICS~AICS Course Directors • Pediatric Cardiologists • Imaging Specialists
~ Page 18 • Congenital/Structural • Electrophysiologists
Cardiologists • Congenital/Structural
CONGENITAL CARDIOLOGY TODAY
Editorial and Subscription Offices • Interventionalists Failure Specialists
16 Cove Rd, Ste. 200 • Echocardiographers • Cardiac Intensivists
Westerly, RI 02891 USA
www.CongenitalCardiologyToday.com
For more information and pricing: [email protected]
www.picsymposium.com
TOSHIBA
Leading Innovation ))
TToosshhiibbaa ggiivveess yyoouu aa vvooiiccee..
AAtt TToosshhiibbaa,, wwee ggoo bbeeyyoonndd lliisstteenniinngg aanndd ggiivvee yyoouu aa vvooiiccee..
CcoOMMpPUUTTEEDD1 T'OoMMoOGGRRAApPHHYY
BBeeccaauussee uunnddeerrssttaannddiinngg yyoouurr bbuussiinneessss iiss oouurr bbuussiinneessss,,
yyoouurr cchhaalllleennggeess bbeeccoommee oouurr cchhaalllleennggeess,, aanndd ttooggeetthheerr,, MMAAGGNNEETTIICC RREESSOONNAANNCCEE
wwee fi nndd ccrreeaattiivvee wwaayyss ttoo ssoollvvee tthheemm.. WWiitthh ddeeccaaddeess ooff
eexxppeerriieennccee aanndd ggrroouunnddbbrreeaakkiinngg tteecchhnnoollooggyy bbuuiilltt iinnttoo PPEETT//CCTT
aallll ooff oouurr pprroodduuccttss,, yyoouu ccaann sseeee yyoouu'’rree aaccttuuaallllyy bbeeiinngg
hheeaarrdd.. IItt'’ss nnoott jjuusstt lliipp sseerrvviiccee.. UULLTTRRAASSOOUUNNDD
VVAASSCCUULLAARR XX--RRAAYY
XX--RRAAYY
©©TToosshhiibbaa AAmmeerriiccaa MMeeddiiccaall SSyysstteemmss 22001144.. A‘ll rights reserved. mmeeddiiccaall..ttoosshhiibbaa..ccoomm
platform vendors so that you may bring this evolving technology to
your patients.
On Friday, September 18th, the morning will begin with Live Case
Transmissions. We will continue with the popular Taped Case Ses-
sions over lunchtime with three taped cases presented and dis-
cussed on both Friday and Saturday. The afternoon sessions will
include a session focused on QA/QI issues for the Cath Lab, and
also discuss new accreditation benchmarks that are evolving, as
well as how registries can meaningfully help us to improve the serv-
ice we provide. Friday will finish with Oral Abstract Presentations
with the best abstracts going forward to an abstract final presenta-
tion on Sunday lunchtime. We have had over 180 abstract submis-
sions from all over the globe, and we are committed to ensuring
that the scientific efforts of our colleagues are given the attention
they deserve so that we may all learn from their innovation.
On Saturday, September, 19th, live cases will be followed by a spe-
cial collaborative joint session with the Congenital Surgeons dis-
cussing opportunities and obstacles for development of hybrid
techniques. This is a pivotal opportunity for us to discuss the bene-
fits and challenges of hybrid therapies, and we are hopeful that this
session will provide a platform for a working document on hybrid
therapies for congenital and structural heart disease. We are hon-
ored this year to have a number of world-renowned surgeons as
part of our faculty including Professor Sir Magdi Yacoub, one of the
pioneers of congenital heart surgery and cardiac transplantation.
There will be a Structural Heart Breakout session entitled “Innova- V
tions in Structural Heart Disease.” There will be further breakout PediatricandAdult lnterventional CardiacSymposium
sessions for nurses and technologists and younger interventional-
ists who are establishing their practice, as well as continuation of
the special breakout for our Spanish-speaking attendees.
Other popular sessions, including “My Nightmare Case in the Cath PICS ~AICS IS SPONSORED BY
Lab” and “Meet the Experts” ensure opportunity for discussion and
learning from each other’s experiences. The final afternoon will
provide a competitive feel as the girls will challenge the boys to a M
f\ RUSH UNIVERSITY
“Best Case” lunchtime session followed by a “Battle of the Conti- dz
nents,” a quiz-based session on all aspects of catheterization with MEDICAL CENTER
the winner claiming global victory and dominance!
\/
Sponsored for CME credit by Rush University Medical Center
Poster abstracts will be displayed throughout the meeting. We will
continue to support younger interventionalists through the PICS
Young Leadership Program, with the winner receiving faculty status
and involvement in the meeting. We also wish to recognize those
committed to research with The Charles S. Kleinman, MD Scientific -'='J'=f|-I-ll-ll
Scholarship Award, given in memory of our dear friend Dr. Charlie
Kleinman, who was so close to the PICS family. The winner will
receive a $5,000 grant towards his/her research endeavor.
Sldra
We look forward to welcoming you to back to Las Vegas. Please
don't forget to get in shape for the 5K Run, which promises to be
memorable this year! It supports a great cause: providing funds for
equipment for mission trips to the developing world. Your participa- .u.,lJ[g__-J=:l1a,L:mJ[ ,4,
tion is what makes the meeting the success that it is, and we look
forward to learning with and from you. Sitira rl.-'!L=Li1'I_'a|.IInd Flttemurtln [1-_‘11|Z1f‘I'
Yours truly,
;'u'r.*1m’Ja_='r {sf Q_r:!.rn'§’funrdr1r:'.r:rI
Ziyad M. Hijazi and Damien Kenny
on behalf of Course Directors and Co-Directors
I " @RushMedical (www.Twitter.com/RushMedical)
CCT
www.facebook.com/RushUniversityMedicalCenter
Tnu www.youtube.com/rushmedicalcenter
The PICS Foundation in collaboration with the Rush University Medical Center.
CONGENITAL CARDIOLOGY TODAY ! www.CongenitalCardiologyToday.com ! Special PICS~AICS Preview - July 2015 3
SEPTEMBER 17th - THURSDAY SESSION
Sponsored for CME Credit
Collaboration to Counter Complexity: by Rush University Medical Center
The Future of Congenital and Structural Interventions
Special One Day Industry-Sponsored Symposium at Rush University Medical Center is accredited by the Accreditation
PICS~AICS Council for Continuing Medical Education to provide continuing
medical education for physicians. Rush University Medical Center
Moderators: John Cheatham, Ziyad M. Hijazi designates this live activity for a maximum of (35) AMA PRA Cate-
gory 1 Credit(s)™. Physicians should claim only credit commensu-
6:00-8:30 pm - Innovations in Imaging for Congenital and rate with the extent of their participation in the activity.
Structural Heart Disease Interventions - Just How Far Can
They Take Us? Rush University is accredited as a provider of continuing nursing
• Siemens education by the American Nurses Credentialing Center's Commis-
• Toshiba sion on Accreditation. Rush University designates this live activity for
• Philips (35) Continuing Education credit(s).
This activity is approved for a maximum of 28 credits by the Ameri-
can Society of Radiologic Technologists (ASRT)
This activity is being presented without bias and with commercial
support.
4 CONGENITAL CARDIOLOGY TODAY ! www.CongenitalCardiologyToday.com ! Special PICS~AICS Preview - July 2015
%Mecl:tronic I I
& COVIDIEN
WelcomingCovidien toMedtronic
!"#$!%$&'
(&$)!*+#'
,' $)+*+#-./'
*'++"0)!*"+1
INNOVATIONS
HPIuBlsE9e'"OJx?iKm9e;t<ryL',M=o>n?i;to=r<i?n>gC'Mf=o<r'(C(C%HND'1S@c<r9e9e>n?i>ngC
!T<rOa>nEs@cOa;tDh9e;t9e<r'Oa>nd:'1SIu<rCg?ic@aOlB'%H9eOa<r;t'0VOaBlvFe9sE
(cid:18)C(cid:286)e(cid:396)r(cid:286)e(cid:271)b(cid:396)r(cid:258)a(cid:367)l(cid:876)/S(cid:94)(cid:381)o(cid:373)m(cid:258)a(cid:415)tic(cid:272)(cid:3)(cid:68)M(cid:381)o(cid:374)n(cid:349)i(cid:410)to(cid:381)r(cid:396)i(cid:349)n(cid:374)g(cid:336)
"OJxLyCg9e>nOa;to=r<sE'Oa>nd:'-F?iBl;t9er<sE
(cid:4)A(cid:271)b(cid:367)l(cid:258)a(cid:415)tio(cid:381)n(cid:374)(cid:3)(cid:100)T(cid:286)e(cid:272)c(cid:346)h(cid:374)n(cid:381)o(cid:367)lo(cid:381)g(cid:336)i(cid:349)e(cid:286)s(cid:400)
&R0V"O!T'(C=o>n:dIu?i;tsE
HPOa@c9eKmOaPk9e<rsE
(COa>n>nIulBaOe9
*l(CDNSE
PLEASE
VISIT OUR
BOOTH AT
PICS/AICS 2015! '69%;30=3<5%89>>2113=%
19%173%;2?312>3%>040:3>341%9?%%
/0123415%6217%894:34210;%730<1%=253053.
!E"VE!R#Y$%&S'TE!P(%)OF*%'TH+E!%,WA-Y$..
.U(C22304156304l144665E$N+'7©22031458',M9e:d;tr<o=n>[email protected]')ABllB'<r?iCgDht;sE'<r9eEs9e<rvFe9d:.A'3O56G/22301458
SEPTEMBER 18th - PICS FRIDAY SESSION SEPTEMBER 18th - PICS FRIDAY SESSION
8:00-8:10 am - Welcome - Ziyad M. Hijazi 2:00-3:30 pm - Breakout Session - QA/QI and Accreditation
for the Cath Lab - Moderators: Alexander Javois, Larry Latson,
8:10-8:20 am - Live Case 2014 Update – Kiran Mallula Ralf Holzer
• What Is Quality? Strategies for Quality Improvement and
8:25-10:30 am - Live Cases - (Riyadh, Córdoba, São Paolo) - Assurance, National and International (One Shoe Does
Moderators: Ziyad M. Hijzai, John Cheatham Not Fit All) – Ralf Holzer
Digital Moderators: Damien Kenny, Bryan Goldstein • Accreditation for Congenital Cardiac Catheterization
Panelists: BG Alekyan, Carlos Zabal, Daniel Gruenstein, Laboratories- Will it Improve Quality? – Larry Latson
Alexander Javois, Seong-Ho Kim, Ali El-Halabi • IMPACT – We Are Listening!! – Robert Vincent
• C3PO – QI: Why Multicenter QI Initiatives Are Important
10:30-10:45 am - Coffee Break – Lisa Bergersen
• QA in Developing Countries; How to Achieve High
10:45-12:45 pm - Live Cases - (Riyadh, Córdoba, São Paolo) - Quality with Limited Resources – Francisco Garay
Moderators: John Carroll, Thomas Jones • Putting It Together Locally: Real Patient Impact of QA/QI
Digital Moderators: Alexander Javois, Reda Ibrahim – Andrew Glatz
Panelists: Francisco Garay, Thomas Fagan, Makram Ebeid, • Discussion
Roberto Cubeddu, Maiy El Sayed, Nguyen Lan Hieu
2:00-3:30 pm - PICES Breakout Session
12:45 - Lunch Available
3:15-3:45 pm - Coffee Break / Visit Exhibits
1:00-2:00 pm - Lunchtime Session - Taped Cases
Moderators: Dave Balzer, Aimee Armstrong 3:45-5:45 pm - Abstract Presentations
• Brent Gordon Room 1: Moderators: John Bass, Girish Shirali, Marco Papa
• Bryan Goldstein Room 2: Moderators: Teiji Akagi, Michael de Moor, JV DeGiovanni
• Jeremy Asnes
5:50-6:00 pm - PICS Award
2:00-3:30 pm - Congenital and Structural Interventions - What
We Can Learn from Each Other - Moderators: John Carroll, 6:00-8:00 pm - Welcome Reception
Neil Wilson, Ziyad M. Hijazi
• Imaging: Transesophageal Echocardiography - What the
Congenital Guys Showed Me – Rebecca Hahn
• Technique: General Anesthesia, Blood Preservation,
Hemostasis Devices, Transseptal Puncture, Dual Antiplatelet
Therapy – Clifford Kavinsky
• Physiology: Measuring Shunts, Flows, or Just Taking the
Path of Least Resistance? When and Why Make the Effort?
– Jamil Aboulhosn
• Devices: Necessity as the Mother of Invention, From PDA
Devices to the Ventricular Septum, the Left Atrial Appendage
and Paravalvar Leaks – Horst Sievert
• Stents / Advanced angioplasty: Thanks for Showing Us the
Way – Felix Berger
• Evolution: Bonhoeffer to Cribrier, Why Everyone Wins. Our
Shared Property Encourages Industry to Listen and Maintain
R&D – Thomas Jones
6 CONGENITAL CARDIOLOGY TODAY ! www.CongenitalCardiologyToday.com ! Special PICS~AICS Preview - July 2015
SEPTEMBER 19th - PICS SATURDAY SESSION
8:00-8:15 am - Special Lecture: Transcatheter ASD Closure –
40 Years Old - Terry King
8:20-10:20 am - Live Cases - (Mumbai, San Diego, Las Vegas) -
Moderators: Giacomo Pongiglione, Eric Horlick, William Hellenbrand
Digital Moderators: Henri Justino, Daniel Gruenstein
Panelists: Mazeni Alwi, Jacek Bialkowski, Sertac Cicek Thomas
Forbes, Jacqueline Kreutzer, Levent Saltik
10:20-10:45 am - Coffee Break
10:45-12:45 pm - Live Cases (Mumbai, San Diego, Las Vegas) -
Moderators: Shakeel Qureshi, Mario Carminati, Damien Kenny
Digital Moderators: Daniel Levi, Lynn Peng
Panelists: Wei Gao, Worokan Promphan, Kanishka Ratnayaka,
Mark Reisman, Raul Rossi, Shyam Sathanandam

1:00-2:00 pm - Lunch Session - Taped Cases
Moderators: David Nykanen, Julie Vincent, John Cheatham
• Mark Osten
• Christopher Petit
• Frank Ing
2:00-5:30 pm - Joint Session with the Congenital Heart
Surgeons – Building a Successful Hybrid Program – The
Collaborative Approach - Moderators: Michel Ilbawi,
Damien Kenny
• Hybrid Approaches in CHD – A Slow Starter or Past Its
Prime?
• The Interventionalist’s Viewpoint: Dietmar Schranz
• The Surgeon’s Viewpoint: Christopher Caldarone
• Cardiopulmonary Bypass – Myths and Truths
– Massimo Caputo
• “I Just Don't Like the Hybrid Room” – Lessons for the
Future – Mark Galantowicz
• No Way In – Hybrid Approaches to Access the Heart in
Neonates with Critical Outflow Tract Obstruction
– Darren Berman
• Perventricular VSD Closure – Pushing the Boundary
– Zahid Amin
• Working Together – Are There Lessons to be Learnt from
the Heart Team Concept in Structural Heart Disease?
– Roberto Cubeddu
• Exit Angiography – Is it Worth the Hassle? – Ralf Holzer
• Discussion and Break
• Pulmonary Valve Replacement – An Opportunity to Build
• Interventional Perspective: Frank Ing
• Surgical Perspective: Alistair Phillips
• Cases and Discussion:
• Carotid Cutdown for Ductal Stenting in a Neonate
with Duct-Dependent Circulation – Mazeni Alwi
• Perventricular Closure of Perimembranous Defects
– Alexander Y. Omelchenko
• Hybrid Interventions on the Pulmonary Arteries – When
Can We Stent and When Should We Patch? – Sertac Cicek
• Optimizing Decision-Making in Planning a Hybrid
Procedure – Julie Vincent
• Debate: The Hybrid Approach to HLHS Should Remain
on the Reserves Bench – A Data Driven Debate and
Discussion
• Pro: Michel Ilbawi
• Con: Lee Benson
• Discussion
CONGENITAL CARDIOLOGY TODAY ! www.CongenitalCardiologyToday.com ! Special PICS~AICS Preview - July 2015 7
SEPTEMBER 19th - PICS SATURDAY SESSION SEPTEMBER 19th - PICS SATURDAY SESSION
2:00-5:30 pm - Breakout Session - Innovations in Structural 2:00-5:30 pm - Breakout Session - Nursing and Associated
Heart Disease - Moderators: Robert March, Clifford Kavinsky, Professionals - Moderators: Sharon L. Cheatham, Mary
Ziyad M. Hijazi Heitschmidt, Kathleen Nolan
• Mitral Valve and the Left Atrial Appendage • Quality and Safety in the Cath Lab – Mary Heitschmidt
• Anatomy Wet Lab Demonstrations – Mark Reisman • Simulation – Elaine Sigalet
• Approval of the WATCHMAN!Are There Still • Transition from the Clinical Cath Lab to the Animal Lab
Unanswered Questions? – Zoltan Turi – Jason Swinning
• Next Generation Devices!.Will Another Device • Electronic Updates to Families Directly from the Cath
Achieve FDA Approval Within 10 Years? – Saibal Kar Lab & OR – Ashley Hodge
• The Changing Landscape of Percutaneous Mitral
Valve Repair – Horst Sievert 3:00-3:30 pm - Break
• Percutaneous Mitral Valve Replacement: Where Will
We Be in 5 Years? – Matt Gillespie • MRI-Guided Transcatheter Therapy – Kanishka Ratnayaka
• Tricuspid Valve Disease • Percutaneous Transcatheter Valve in Valve
• Anatomy Wet Lab Demonstrations – Mark Reisman Replacement – Matt Gillespie
• Case Presentation – John Carroll • CT Surgeon’s Role in Intervention in the Modern Day
• Heterotopic Valve Replacement for Severe TR – Cath Lab – Mark Galantowicz
Doomed to Fail or a Niche Market? – Hans Figulla • “Analyze This” – Interactive Session (An interactive
• Percutaneous Tricuspid Valve Repair for Chronic session with audience participation and prizes) – Kathleen
Tricuspid Regurgitation: The Mitralign Device Nolan, Jason Swinning
– Scott Lim
• Trans-Atrial Intrapericardial Tricuspid Annuloplasty 5:35-6:35 pm - Meet the Experts
– Robert Lederman • Room 1 – Michael Tynan, Mario Carminati
• The Current State of Valve-in-Valve Tricuspid • Room 2 – Charles Mullins, Horacio Faella
Technology for Failed Bioprostheses
– Doff McElhinney
3:45-4:00 pm - Break
• Aortic Valve Disease
• Anatomy Wet Lab Demonstrations – Mark Reisman
• Case Presentation – Adam Greenbaum
• Prevention of Catastrophic Complications During
TAVR Procedures – Robert March
• Emerging Transcatheter Aortic Valve Technologies
– Hans Figulla
• TAVR for Aortic Regurgitation – Steve Bailey
• Predictors for Early Discharge after TAVR
– Christian Spies
• Patent Foramen Ovale/Paravalvular Leaks
• Case Presentation – Ziyad M. Hijazi
• FDA Approval: Is There Enough Evidence to Appeal
for Limited Approval for PFO Closure in High-Risk
Patient Subsets – Mark Reisman
• Where Do We Stand with Percutaneous Treatment
of Paravalvular Leaks? – Zoltan Turi
PICS-AICS
-
SE PT. ‘1 1 5
F‘-e-:Ji;It:ir..1nr:JAdultInna-:'\.-s_*:':tinI1.':| C.':rdi.'n:5','|T‘:}JL'hE.iu|'r1
3
8 CONGENITAL CARDIOLOGY TODAY ! www.CongenitalCardiologyToday.com ! Special PICS~AICS Preview - July 2015
! " # $ % & & ' ( )®
*
-
COCO
O!a‘a
+,"'*-./#01*2,3*456*+',/(30
!
"!#"$%&'!%"#(%&!)"*!
! +,!-.,#%
TThhee NNiitt--0Occcc|uludd®® ccooiill ssyysstteemm ffoorr TThhee NNiitt--0Occccluludd®® PPDDAA ccooiill iiss TThhee NNiitt—-O0cccc|luudd®® PPDDAA ccooiill
PPDDAA cclloossuurree iiss ddeessiiggnneedd ttoo mmaattcchh rreeppoossiittiioonnaabbllee aanndd rreettrriieevvaabbllee wwaass ddeetteerrmmiinneedd ttoo bbee MMRRII
iinnddiivviidduuaall mmoorrpphhoollooggiieess aanndd ssiizzeess pprriioorr ttoo rreelleeaassee ccoonnddiittiioonnaall
TThhee ddeelliivveerryy ssyysstteemm ffaacciilliittaatteess TTiigghhtt aanndd ccoommppaacctt wwiinnddiinnggss RRaaddiiooppaaqquuee
ooppttiimmaall ddeevviiccee ppoossiittiioonniinngg eennssuurree eefffificciieenntt oocccclluussiioonn
FFoorr mmoorree iinnffoorrmmaattiioonn oorr ttoo ppllaaccee aann oorrddeerr,, ccoonnttaacctt yyoouurr BB.. BBrraauunn Ilnntteerrvveennttiioonnaall SSyysstteemmss IInncc..
rreepprreesseennttaattiivvee oorr ccaallll 11--887777--VVEENNAA--CCAAVV ((883366--22222288))
mlil lillllll‘
Ii1teI'vei1tiom1I)*
=,, Systems
DDiissttrriibbuutteedd bbyy::
MMaannuuffaaccttuurreerr:: BB.. BBrraauunn Ilnntteerrvveennttiioonnaall SSyysstteemmss IInncc..
ppffmm mmeeddiiccaall,, aagg 882244 TTwweellfftthh AAvveennuuee
WWaannkkeelslstrtaraß ee 6600 BBeetthhlleehheemm,, PPAA 1188001188 UUSSAA
5500999966 KKöiillnn,, GGeerrmmaannyy TTeell:: 11--887777--VVEENNAA CCAAVV ((883366--22222288)) ((UUSSAA))
TT ++4499 ((00))22223366 99664411--1100 FFaaxx:: 11--661100--884499--11333344
FF ++4499 ((00))22223366 99664411--2200 wwwwww..bbiissuussaa..oorrgg
!F$lil:rc"%iinad&#8pli1$cc%1%l&aua2&"nli1'ai&'$io(&ai'ei-"i'ii$:od#()T*+n*"l4Pi,*e#dGV-N-e*RH.1li$il*Ev—$g@'-e/9r0r9O-ey;&%ac*%c%'ic-e&a1l2u9r'i*n,#d'm,-e3®a&'i*e-F4n"r9D5**I57s6,*nwJ*(c%ou2((lo1$'(d#1*d#$*7Mb**Ku&-e*n*"82ui$-7is's79e-):Ld#.=**&'Ll',o("h9*-m($i:m":m'8p1M;h1l&*2ua$':"s7n'*n8*$i'"nn1,&*e-&a"**'#dMb--e1l#(oEv*o(8i$c%d#9e-(*Ev.B7*-e*'6A,7s#-ds7:m7e-$l17*i$n"i'*n,$'i$"s7r9#o(t'r9$u'2a&%g@t&'i$n,o('-*n"w?#*(o*n,<(<i$i*%c9Is*,i8Qoi*-*a&2i9ic%l"%ic%i2$l'e-s7'&s7*(os7"<*i-*n't,(o(e-*2'tp8,h7a&e-=*r'9*i9$4Pn"&5D*"8p76A-e%*9rm:&*Pk'2l,@gis7-*Mb'l'*(-oMh#d9-e*%y;*a(1*(?wmM7-e'2a&i$g@i9$n-"h,e*-t'(d*#7s<y*=7,h*i:'o(n,u2r&9ol(1d1#1r:**n'Mh(Mo-e*:2u*$i7s"n(*yR#$i-"ne-%*c9't'l,h&-e-e'd#-**vE*&a7i$<$c%l'>e-i$-n"r9*i$*8t'<ly;e-&*m:'(o-<ol("*i'rn9',a&*#e-l1*2*7s$i%:m,n'-2e8p&7a1l&a'*i&,i"ni9s7'r'&a*-&a'i9i$9r$'o((-en"7*8p*2751l&a71$'1*c%-?8e-*$'&ad#',c'B***'mA6&,*"n:e-'i*i$$''loM"i$m:$i$(c:e-i'i$2c*%o(:s7r<***7s'&m,,n"e-(o@*u2$$'i:(il1id#i@p8*9Mol1&a&-e8"l*l@g,l'l'$il$$vE%a(e-*n#"n"$'*&o(*Mo:r9-e*8p-<lo(&a'-r9'te-$i9-e**1F"ln-Ol't77s*#7d**?vo(',vs7$i'&el-,ii")L**&a*&Aa*"n:Mbd#(o:*#d&aB.;y<i*N.'i*e-?w$i9r'i-e*/-$i0r:$im@g‘%h,8p%t'1l&*a12N<"n#*'rO1*&aCO1'i*i$9o(1$lMb-n"7s<***DF(F(S2I5'*&*#dPk'(o-@g7s:)L-e.B*-s7*6A")L*n"'$i)n"**5&a*(o"n(9r@g*#d"i$-o((e9g@'r**i'$r9o:(a&*r:88pn19r*&-e:r"nEv'2u-e*'7s"n,'i'i-**Mb$l*"i.-eil<e$*-''8p/c%0-oel'l$9cro(%<ic(cr%"llr91*u2m:#dd#2ue-*9r4Fd#$i"nF5*8g@p‘69*r'i$i*n,(o$"e-9r'*(*'t$i(o:m*8*$i&8p:rn'1l&$a'8p-"n1l"&a'i'*"n87p'i*9ra?&(oi',%ic$o(-e(n"#d*,*u2i<&o(r9Ee-r9-*B:m**5-D-e"(o&a#*7"sn(2u(o%9r'&ii$*in"$r9:n#g@$p"8*'1l$-1le7&a"n="n*-@g'n*"'ir'n,in,#r*le-a&&an*9n".N'ed#-$ri'*9ii/d.#v$o'0i$i$&a7o%=:mc*%&i1r-e%2r'ld'#e-$E*r94F-*o(D5*$<"l*A6i'<n,-*$ie-"%n'**$&'a4P(n"5D"*=TAM6*8.BHR2**1*0o:-en""n(l1vEy;"i$*r9&'mo(,9n";ye-r*:,*n8p;-e<i8m:"n-'i*.B9:*m'*-5D-e"o(#d7*i$"$‘rc%(i(am&"l'1***
8(cid:72)(cid:85)(cid:76)peri(cid:80)r(cid:72)e2(cid:91)uxnr(cid:84)(cid:83)(cid:83)lp1prl1(cid:88)u*(cid:79)(cid:72)el'i(cid:68)ai(cid:76)l,n(cid:85)r(cid:85)i(cid:81)n(cid:76)ei(cid:76)-'(cid:72)e(cid:81)n(cid:87)l*(cid:68)a(cid:81)n(cid:74)g.li(cid:87)i(cid:70)c(cid:3)ii(cid:76)$i(cid:80)c(cid:82)m(cid:72)e'./no(cid:81)s(cid:86)0(cid:72)e(cid:3)(cid:3)cd(cid:71)(cid:68)a(cid:82)%oci(cid:76)(cid:79)%l(cid:73)ci(cid:70)(cid:79)ll(cid:3)(cid:72)e1ua(cid:87)(cid:68)i2n(cid:75)(cid:85)rld(cid:79)#(cid:74)g(cid:3)e(cid:72)i(cid:87)*(cid:76)ir(cid:3)%(cid:85)(cid:70)cc(cid:82)eo(cid:72)o((cid:3)(cid:86)sc(cid:70)a(cid:68)i$l(cid:92)1yc(cid:70)(cid:87)i*im'(cid:80)(cid:80)ml(cid:79)n,u(cid:88)r9(cid:72)de(cid:83)p(cid:71)c(e(cid:81)(cid:87)nt(cid:72)u(cid:82)2on(cid:87)(cid:85)ig(cid:3)(cid:80)m@(cid:15)(cid:82)(cid:3)on,(cid:43)Hs(cid:86)(cid:85)r*(cid:3)‘(cid:15),(cid:92)ly(cid:83)p(cid:3)i(cid:83)e(cid:86)s-p(cid:68)a(cid:88)u(cid:72)ea&(cid:70)c(cid:70)c(cid:85)r9n(cid:76)i(cid:87)t'(cid:81)n(cid:75)n(cid:72)e*Ev(cid:74)(cid:3)gn(cid:81)(cid:68)a&a(cid:15)s(cid:86)(cid:3)s(cid:86)1lA(cid:36)vEi(cid:76)(cid:3)o(cid:82)(cid:71)de-n(cid:85)n(cid:81)(cid:87)(cid:76)is7e(cid:73)m(cid:72).(cid:15)(cid:191)*(cid:3)n(cid:85)(o(cid:70)(cid:43)ci(cid:76)lc(cid:82)9r(cid:88)cy*(cid:92)v(cid:89)Evl(cid:79)pr(cid:83)(cid:87)e(cid:72)-e(cid:92)yo(cid:82)n(cid:81)"(cid:3)lri(cid:76)i(cid:87)o(cid:82)(cid:81)ln'e(cid:72)r9i(cid:88)(cid:3)ln$(cid:81)r(cid:69)co%s(cid:86)s(cid:86)u2(cid:85)r(cid:3)(cid:72)i(cid:76)e1lcn(cid:191)(cid:82)&a(cid:68)a(cid:86)ns(cid:81)9r(cid:87)i(cid:87)l*(cid:3)(cid:75)clu(cid:88)%i(cid:82)oih(cid:76)l,(cid:79)n(cid:81)a(cid:85)r(cid:68)a(cid:3)&g(cid:74),(cid:15)(cid:86)sm(cid:3):(cid:3)(cid:75)n(cid:37)(cid:82)oBb(cid:82)aM(cid:85)r(cid:68)a(cid:3)c(cid:70)-e(cid:86)(cid:70)sck(cid:78)9l(cid:90)w(cid:87)ts7,(cid:72)e(cid:15)(cid:3)(cid:72)eB(cid:85)r(cid:44)l*i(cid:76)(cid:81)lUl(cid:79)Ca(cid:68)li(cid:79)i(cid:76)l(cid:73)n(cid:81)le(cid:79)((cid:72)u(cid:3)g(cid:74)"e(cid:72)c(cid:70)ll(cid:3)n'(cid:81)i(cid:87)l(cid:82)io9l(cid:76)od(cid:82)d(cid:71)&(cid:73)i(cid:3)c(cid:81)l(cid:82)7i(cid:87)ino,(cid:75)(cid:15)'(cid:70)r(cid:3)*ae(cid:72):(cid:68)(cid:48)Mr(cid:3)(cid:85)d(cid:73)l-(cid:71)(cid:92)ya(cid:68)i#(cid:82)o(cid:76)rc(cid:70)(cid:87)i$(cid:76)(cid:70)'cse(cid:72)&(cid:86)a(cid:68)r(cid:3)(cid:15)*(cid:82)o7(cid:3)r(cid:85)(cid:37)d(cid:71)B,(cid:85)r(cid:3)i(cid:76)(cid:79)l((cid:87)at(cid:68)(cid:82)o(cid:75)h2l(cid:79)o(cid:82)(cid:85)r(cid:3)1o(cid:82)(cid:76)di(cid:71)#(cid:81)na(cid:68)(cid:3)*(cid:73)i"(cid:79)lat(cid:68)(cid:87)(cid:82)c,(cid:15)(r(cid:85)(cid:3)s(cid:86)(cid:75)ch(cid:70)'s(cid:86)*l(cid:87)(cid:72)eMi(cid:76)(cid:3)o(cid:82)(cid:18)l-(cid:85)rs(cid:86)(cid:72)en(cid:81)*h(cid:75)$i(cid:84)q,(cid:15)"ie(cid:3)r(cid:72)u(cid:88)Rj(cid:50)o-e(cid:3)i(cid:76)s(cid:86)rc(cid:85)c%(cid:70)i(cid:76)n(cid:75)cnr(cid:81)'(cid:70)e-o(cid:82)lg(cid:74)(cid:79)u(cid:88)ei#(cid:88)r(cid:3)d(cid:71)l*(cid:87)(cid:79)id'(cid:71)r(cid:85)e(cid:72),a(cid:68)(cid:3)(cid:85)r9(cid:69)bn(cid:81)(cid:3)(e(cid:72)i(cid:73)(cid:86)sr2(cid:85)(cid:3)a(cid:73)l(cid:68)(cid:76)ui@(cid:88)(cid:81)nc(cid:70)s,(cid:86)(cid:86)sl(cid:87)iu(cid:76)*(cid:88)(cid:87)tc(cid:82)'(cid:85)r,r(cid:85)n(cid:88)u(cid:81)e(cid:72)-.(cid:70)c(cid:15)(cid:3)(cid:3)*t(cid:87)(cid:82)o$'(cid:38)ce(cid:72):(cid:85)rld(cid:71)(cid:75)(cid:3)i8(cid:71)ed(cid:3)(cid:72)(cid:87)l1(cid:68)ao&s(cid:82)(cid:86)(cid:80)m"(cid:3)i(cid:87)(cid:86)s(cid:3)'(cid:83)a(cid:68)p(cid:72)e&(cid:68)ag(cid:74)e(cid:72)'$(cid:76)ie(cid:72)k(cid:78)(n(cid:81)‘(cid:3)(cid:15)",(cid:15)(cid:80)(cid:3)m(cid:3)(cid:51)*P(cid:39)D%(cid:72)e(cid:72)e&(cid:68)a(cid:71)d(cid:85)r'(cid:80)m(cid:73),i(cid:76)frc(cid:70)(cid:82)o-a(cid:68)(cid:68)a(cid:85)r'(cid:68)al(cid:74)(cid:79)g-(cid:3)t(cid:87)(cid:68)a(cid:72)e9i(cid:76)o(cid:82)B(cid:86)s(cid:3)**n(cid:87)l(cid:81)(cid:86)s+o(cid:82)(cid:76)(cid:3)i(cid:86),s(cid:3)c(cid:82)(cid:87)it(cid:87)-l(cid:75)(cid:73)la(cid:68)i(cid:3)e*(cid:72)(cid:87)mn(cid:81)%(cid:75)(cid:3)&c(cid:70)(cid:72)e(cid:87)ien(cid:85)(cid:72)'(cid:3),(cid:76)c(cid:70)(cid:3)(cid:75)l(cid:76)-iiu(cid:80)(cid:88)me(cid:72)'s(cid:86)-(cid:68)a(cid:80)rp(cid:83)n9(cid:85)r*i(cid:87)(cid:76)i(cid:72)e:d(cid:3)(cid:71)(cid:82)o(cid:71)d(cid:3)2r(cid:85)(cid:82)o(cid:76)ia(cid:68)(cid:3)7r(cid:85)(cid:69)bi(cid:87)(cid:3)'re(cid:72)*(cid:79)l(cid:83)p"(cid:82)ol(cid:79)ym(cid:88)u(cid:92)o((cid:82).(cid:17)(cid:79)ld'(cid:71)(cid:3)m(cid:80)l(cid:36)*AM(cid:3)vo(cid:89)(cid:82)(cid:81)n-e(cid:72)n(cid:81)(cid:87)l*(cid:76)l%s(cid:86)(cid:69)ha(cid:68)(s(cid:86)(cid:76)ri(cid:85)(cid:82)ny(cid:92)"e(cid:72)(cid:87)l(cid:3)"l(cid:79)l(cid:76)s(cid:86)v(cid:89)c(cid:70)-,a(cid:15)(cid:68)(cid:3)(cid:3)(cid:83)%pl(cid:79)(cid:54)sv(cid:89)'(cid:85)r-v(cid:82)oe(cid:87)(cid:72)(cid:72)e#(cid:83)ps(cid:86)(cid:81)n*,(cid:75)(cid:15)n't(cid:3)(cid:82)c(o(cid:92)y(cid:39)n(cid:86)s*l(cid:79),ea(cid:68)(cid:72)i(cid:76)s(cid:86)$'x(cid:91)a(cid:68)@(cid:3)i(cid:76)(cid:82)io(cid:87),s(cid:86)n(cid:75)(cid:73)(cid:3)l*,(cid:3)8(cid:15)(cid:86)s(cid:3)(cid:87)th(cid:75)9(cid:75)h(cid:40)E-o(cid:82)e(cid:72)(cid:80)i7ui(cid:88)(cid:3)i7(cid:79)hll(cid:69)(cid:79)(cid:72)ed(cid:71)2o(cid:82)(cid:73)l(cid:3)9(cid:87)il(cid:69)(cid:79)b-(cid:3)l(cid:76)z(cid:83)p(cid:93)e(cid:72)*$a(cid:68)i(cid:88)u(cid:3)"n(cid:83)pl(cid:87)(cid:79)lRjl(cid:80)m(cid:76)-(cid:72)eea(cid:82)%(cid:85)crr(cid:81)o(cid:82)(cid:73)ll'to(cid:82)(cid:3)n(cid:81)(oc(cid:82)r(cid:85)a(cid:68)r9r(cid:80)(cid:73)ls7nr(cid:85)(cid:3)y(cid:92)Bi(cid:87)e(cid:72)n*(cid:75)(cid:3)*d4(cid:71)i(cid:68)ae(cid:72)=(cid:3)(cid:85)&n(cid:3)(cid:87)at(cid:87)(cid:82)c(cid:82)o'e(cid:72)i$ci(cid:70)(cid:3)-er(cid:85)(cid:83)pc(cid:70)(cid:92)y"n(cid:85)rl(cid:79)(cid:3)u(cid:72)(cid:88)e'io(cid:82)7sd(cid:89)(cid:71)v(cid:85)r*:(cid:72)e(cid:3)em(cid:72)(cid:71)d(cid:81)rn(cid:85)&a,(cid:72)e(cid:15)(cid:87)t(cid:3);(cid:3)y(cid:86)s"(cid:85)i(cid:76)e(cid:81)*(cid:72)c(cid:70),q(cid:73)(cid:84)e(cid:72)&(cid:72)u(cid:88)n(cid:81)E(cid:70)d(cid:76)(cid:71)i-(cid:87)(cid:85)r(cid:76)i(cid:76)(cid:76)l(cid:89)*n(cid:81)(cid:81)l&i(cid:72)gg(cid:74)(cid:74)"(cid:3)(cid:3)(cid:3)(cid:72)*i(cid:83)(cid:87)&pn(cid:75)(cid:81)(cid:72)e1o1(cid:82)(cid:71)4-(cid:85)rr(cid:85)(cid:70)(cid:82)c9a(cid:68)@(cid:88)u(cid:70)c(cid:70)r$(cid:87)(cid:68)%i(cid:68)(cid:76)a(cid:70)c(cid:85)-*(cid:81)n4(cid:71)9(cid:3)-(cid:68)a(cid:72)e(cid:76)(cid:87)7o(cid:82)o(cid:82)(cid:76)(cid:86)8n(cid:85)u(cid:88)(cid:3)(cid:87)a((cid:71)4s(cid:68)(cid:86)y"(cid:88)(cid:3)(cid:15)(cid:3)(cid:82)o7(cid:85)(cid:54)S(cid:76)(cid:85)r-(cid:81)(cid:3)(cid:87)l*r(cid:86)(cid:74)(cid:85)gs'o(cid:82)((cid:88)u(cid:3)(cid:191)lk(cid:78)*(cid:85)ri'(cid:85)ig(cid:74)e(cid:72),*s(cid:86)i(cid:76)i(cid:18)$c(cid:87)(cid:70)T((cid:55)7(cid:3)6a(cid:68)(cid:25)*|(cid:44)#A(cid:36)l(cid:79)(cid:3)(cid:3)(cid:80)-m.(cid:76)(cid:15)i(cid:81)(cid:3)nE(cid:82)T(cid:55)o(cid:87)$l%(cid:72)e(cid:81)n(cid:75)h-(cid:85)r(cid:87)i(cid:85)ln(cid:75)v(cid:89)o*(cid:82)#es(cid:72)(cid:86)l(cid:80)i2(cid:3)n(cid:81)ia(cid:68)b-(cid:69)i(cid:87)ii(cid:73)(cid:76)oor*(cid:82)(cid:82)(cid:87)'e(cid:72)(en(cid:72)(cid:81)i(cid:85)*l,(cid:80)(cid:15)(cid:3)7i(cid:3)(cid:70)ib:(cid:40)E(cid:69)(cid:82)o(cid:81)n(cid:82)(cid:76)'&(cid:79)l(cid:3)(cid:71)d(cid:79)1i(cid:76)(cid:76)1s(cid:80)(cid:86)(cid:68)*a&m(cid:80)(cid:85)n(cid:83):(cid:87)(cid:72)e(cid:79)(cid:3)(cid:68)(cid:11)(l(cid:85)rc(cid:70)(cid:76)(cid:81)i2(cid:87)ie(cid:72)i(cid:76)(cid:87)s"(cid:86)(cid:68)r(cid:85).e(cid:15)'(cid:72)(cid:87)(cid:3)7(cid:76)o(cid:69)(cid:41)(cid:82)F*(r(cid:85)(cid:81)(cid:68)aa(cid:68)<(cid:17)(cid:79)l*l(cid:86)(cid:3)s(cid:79)"i(cid:3)(cid:51)Fi(cid:72)ei(cid:82)o$u%(cid:82)(cid:3)(cid:85)rsP(cid:68)a(cid:3)(cid:87)(cid:72)(cid:83)e-p(cid:81)n(cid:81)(cid:88)iu1(cid:72)e*'(cid:87)(cid:79)lu(cid:88)u,(cid:80)m(cid:76)(cid:68)ir(cid:85)&ay(cid:92)(cid:79)o(cid:82)-(cid:3)'i(cid:36)Ms(cid:86)n*(cid:81),m(cid:80)(cid:71)a(cid:68)&r(cid:89)(cid:85)(cid:3)7y(cid:92)(cid:72)o(cid:82)*)(cid:12)M(cid:85)r(cid:73),(cid:15)(cid:3)(cid:86)(cid:3)-(cid:87)m(cid:57)v(cid:72)(cid:75)-a(cid:68)(cid:3)(cid:72)e"(cid:40)El(cid:79)(cid:3)v(cid:89)*(cid:89)i7(cid:73)vue(cid:88)(cid:72)(cid:72),el(cid:79)n(cid:80)(cid:81)a(cid:68)(iii(cid:87)lr(cid:85)?c(cid:82)s(cid:86)(cid:3)r(cid:85)(cid:53)R(cid:29)"a(cid:68)(cid:3)A(cid:36)*(cid:72)el(cid:79)'(cid:3)((cid:76)i(cid:74)g(cid:85)(cid:68)ra*(cid:3)e(cid:88)uM(cid:85)rr(cid:72)t(cid:87)r(cid:85)r-(cid:80)e(cid:72)ng(cid:74)*r(cid:85)i(cid:76)9iy(cid:69)i(cid:87)(cid:92)r-a(cid:68)c.(cid:15)(cid:82)1(cid:3)l(cid:87)l-i(cid:79)(cid:41)i(cid:76)Fo(cid:76)s(cid:82)&(cid:86)(cid:72)enm(cid:81)(cid:80)7(cid:89)vr(cid:15)-,e(cid:72)(cid:3)(cid:15)(cid:57)#v(cid:3)r(cid:85)(cid:36),(cid:15)e*(cid:72)(cid:43)<l(cid:79)9s(cid:79)l(cid:86)(cid:72)u((cid:72)es(cid:86)(cid:85):l(cid:68)ea(cid:72)l(cid:74)l(cid:71)ld(cid:79)(cid:76)*(cid:3)(cid:70)'r(cid:68)a(cid:71),di(cid:3)r(cid:70)(cid:85)c(cid:68)a-e(cid:72)(cid:75)i(cid:80)m*id#(cid:68)e(cid:72)e-a(cid:70)(cid:68)l(cid:18)r(cid:80)(cid:87)vgE(cid:74)n(cid:76)'(cid:82)i$e(cid:72)ic(cid:76)%g(cid:74)(cid:81)(cid:3)e-r(cid:68)(cid:85)a(cid:3)a*(cid:68)(cid:87)$(cid:87)ii(cid:82)n"(cid:3)i(cid:76)n(cid:81)i(cid:87)(cid:3)*n(cid:75)(cid:71)Eve(cid:72)e(cid:72)(cid:85)-e,(cid:15)(cid:88)(cid:3)(cid:3)9r(cid:43)(cid:86)(cid:74)Hs;y(cid:76)i*(cid:18)(cid:72)(cid:87)ie7(cid:70)e(cid:72)(cid:68):a(cid:82)m(cid:3)(cid:85)c(cid:82)n(cid:81)&(cid:87)(cid:3)(cid:73)(cid:87)l1(cid:3)(cid:85)il(cid:73)1iag(cid:74)(cid:68)(cid:68)*&air(cid:85)(cid:76)(cid:86)l(cid:79):o(cid:82)un(cid:88)(cid:87)(cid:15)i(cid:76)l(cid:85)(cid:3)n(cid:81)(e(cid:36)(cid:72)A(cid:3)2-r(cid:15)(cid:83)ip(cid:83)pr(cid:3)"-(cid:81)(cid:43)n(cid:88)i~u'iee(cid:72)7(cid:81)n(cid:72)Ba(cid:68)r(cid:70)c(cid:80)*n!l‘(cid:87)(cid:15)i<iu(cid:88)(cid:3)o(cid:82)*Am(cid:36)'r(cid:85)l,(cid:79)e(cid:85)(cid:72)yn(cid:92)e(cid:85)-s(cid:3)(cid:86)i(cid:75)i(cid:11)*li(cid:76)y8l(cid:92)(cid:79)ps(cid:86)c(cid:82)i&(cid:87)a(cid:3)ls(cid:75)(cid:86)i(cid:68)a'ims(cid:86)$(cid:80)i(cid:73)i-e(cid:87)i(cid:3)ei(cid:72)"(cid:82)on(cid:76)a(cid:68)r(cid:85)'(cid:73)ii*(cid:3)(cid:3)*
8p2ul1s7e-.=*,n-e:m&a'io(m:a&*-e'i%cB.Ll
SEPTEMBER 20th - PICS SUNDAY SESSION SUMMARY LIVE CASES AND OPERATORS
8:00-9:30 am - Update on Clinical Trials - Moderators: Marco
Papa, Robert Lederman, Damien Kenny FRIDAY, SEPTEMBER 18TH
• Device Development and EFS – Meeting Physicians
Halfway – Nicole Ibrahim KFSH&RC
• Atrial Decompression for Left Heart Failure – Hans Figulla Riyadh, Saudi Arabia
• PARCS and COAST II – Close to Covered Stents in the (2 cases)
U.S? – Richard Ringel Mansour Al-Jufan, MD; Fadel AlFadley, MD
• Occlusion Device Studies – Update
• St. Jude ASO – Zahid Amin Private Hospital of Córdoba
• GSO – Scott Lim Córdoba, Argentina
• NitOcclud – John W. Moore (2 cases)
• Left Atrial Appendage Occlusion – Saibal Kar Alejandro Peirone, MD
• MitraClip – Scott Lim
• Medtronic Self-Expanding PV – John Cheatham Instituto Dante Pazzanese de Cardiologia
• Advanta V12 Covered Stent – Elchanan Bruckheimer São Paolo, Brazil
(2 cases)
9:30-11:00 am - Congenital and Structural Interventions Over Carlos Pedra, MD
the Next 15 years - Moderators: Dan Levi, Damien Kenny
• Keynote Lecture: Innovations at What Price? SATURDAY, SEPTEMBER 19TH
– Sir Magdi Yacoub
• Imaging and Interventions on the Lymphatic System In Nanavati Superspecialty Hospital
Complex CHD – Yoav Dori Mumbai, India
• Bioresorbable Stents and Occlusion Devices – Progress (2 cases)
Over the Next 15 Years – Dan Levi Bharat Dalvi, MD; Prafulla Kerkar, MD
• Advances in Stem Cell Technology - How It Will Benefit Us
– Massimo Caputo Rady Children’s Hospital
• Transcatheter Fontan Completion – Initial Experience and San Diego, CA USA
Future Advances – John Cheatham (2 cases)
• Transcatheter Systemic-Pulmonary Shunt in PAH – Will It John W. Moore, Howaida El-Said
Catch On? – Dietmar Shranz
• Treating Heart Failure in the Cath Lab – Applications for Sunrise Children’s Hospital
Congenital Heart Patients – Thomas Jones Las Vegas, NV
• Holography – How It Will Shape Interventions in the Next (2 cases)
15 Years – Elchanan Bruckheimer Alvaro Galindo, MD; Abraham Rothman, MD
11:10 -11:30 am - Coffee Break MONDAY, SEPTEMBER 21ST
11:30 am -1:00 pm - Paying Attention to Access – The Gateway Nationwide Children’s Hospital
to the Heart - Moderators: Daniel Gruenstein, Thomas Fagan, Columbus, OH USA
Thomas Jones (2 cases)
• Percutaneous Carotid Access in Infants for Interventional Darren Berman, MD; Aimee Armstrong, MD
Procedures – Christopher Petit
• Vessel Rehabilitation – Feasibility and Techniques Seattle Children’s Hospital
– Frank Ing Seattle, WA USA
• Acute and Semi-Acute Arterial Ischemia Post (2 cases)
Catheterization - Etiological Factors and Protocols Thomas Jones, MD
for Management – Howaida El Said
• Simple Modifications for Successful Fontan Fenestration Texas Children’s Hospital
– K. Sivakumar Houston, TX USA
• Too Much Metal – Getting Around a Blockade in the Heart (2 Cases)
– Kevin Walsh Henri Justino, MD
• Debate: Interventional Procedures Pre- and Post- CPB –
There Should Be No Time Limits on Either
• Pro: Dan Gruenstein
• Con: Zahid Amin
10 CONGENITAL CARDIOLOGY TODAY ! www.CongenitalCardiologyToday.com ! Special PICS~AICS Preview - July 2015